Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2023

Sep 6, 2023

30786_dirs_2023-09-06_032c2a6d-9397-4309-b7d4-801485618854.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2023-09-01

Reporting Person: ERNST TIMOTHY S (EVP, General Counsel & Sec)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-09-01 Bio-Rad A Common Stock M 347 Acquired 2762.7965 Direct
2023-09-01 Bio-Rad A Common Stock F 173 $394.60 Disposed 2589.7965 Direct
2023-09-01 Bio-Rad A Common Stock M 253 Acquired 2842.7965 Direct
2023-09-01 Bio-Rad A Common Stock F 126 $394.60 Disposed 2716.7965 Direct
2023-09-02 Bio-Rad A Common Stock M 361 Acquired 3077.7965 Direct
2023-09-02 Bio-Rad A Common Stock F 179 $394.60 Disposed 2898.7965 Direct
2023-09-03 Bio-Rad A Common Stock M 464 Acquired 3362.7965 Direct
2023-09-03 Bio-Rad A Common Stock F 231 $394.60 Disposed 3131.7965 Direct
2023-09-04 Bio-Rad A Common Stock M 500 Acquired 3631.7965 Direct
2023-09-04 Bio-Rad A Common Stock F 248 $394.60 Disposed 3383.7965 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-09-01 Restricted Stock Units $0 A 2003 Acquired Bio-Rad A Common Stock (2003) Direct
2023-09-01 Restricted Stock Units $0 M 347 Disposed Bio-Rad A Common Stock (347) Direct
2023-09-01 Restricted Stock Units $0 M 253 Disposed Bio-Rad A Common Stock (253) Direct
2023-09-02 Restricted Stock Units $0 M 361 Disposed Bio-Rad A Common Stock (361) Direct
2023-09-03 Restricted Stock Units $0 M 464 Disposed Bio-Rad A Common Stock (464) Direct
2023-09-04 Restricted Stock Units $0 M 500 Disposed Bio-Rad A Common Stock (500) Direct

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.

F4: On September 1, 2022, the reporting person was granted 1,388 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

F5: On September 1, 2021, the reporting person was granted 1,013 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

F6: On September 2, 2020, the reporting person was granted 1,444 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

F7: On September 3, 2019, the reporting person was granted 2,320 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.

F8: On September 4, 2018, the reporting person was granted 2,500 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.